Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Processa Pharmaceuticals, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Sheila Gujrathi, Director (Form 8-K filed 2026-07-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Soleus Capital Master Fund, L.P. (filed 2026-08-18).
Who is behind it
Processa Pharmaceuticals, Inc.: incorporated in Delaware; business address in Vero Beach, Florida; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-18).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-18 | Soleus Capital Master Fund, L.P. | 5.8% |
| Schedule 13G/A, 2026-05-15 | Cvi Investments, Inc. | 7% |
| Schedule 13D/A, 2026-02-23 | Hx Entertainment LTD | 13% |
| Schedule 13G/A, 2026-02-13 | Mitchell P. Kopin | 8.1% |
| Schedule 13G/A, 2025-11-07 | Cvi Investments, Inc. | 9% |
| Schedule 13D/A, 2025-10-15 | Chiliz Group LTD. | 10.9% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 4.99% |
| Schedule 13G/A, 2025-08-14 | Cvi Investments, Inc. | 9.9% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-29 | Sheila Gujrathi | Director | appointed |
Money raised
Latest IPO step: Processa Pharmaceuticals, Inc. filed its final IPO prospectus, ticker PCSA (424B4, 2025-06-18).
IPO filings: 424B4, 2025-06-18, S-1, 2025-06-13, 424B4, 2025-01-29, S-1/A, 2025-01-27, S-1/A, 2025-01-16; ticker PCSA on Nasdaq Capital Market.
Acquisitions reported on Form 8-K, Item 2.01: acquired Vidya Therapeutics, Inc. (2026-07-29).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/processa-pharmaceuticals